Literature DB >> 26983655

Isoprenoid pathway dysfunction in chronic fatigue syndrome.

Ravi Kumar Kurup1, Parameswara Achutha Kurup2.   

Abstract

BACKGROUND AND AIMS: The isoprenoid pathway was assessed in 15 patients with chronic fatigue syndrome (CFS). The pathway was also assessed in individuals with differing hemispheric dominance to assess whether hemispheric dominance has any correlation with these disease states.
METHODS: The isoprenoid metabolites - digoxin, dolichol and ubiquinone - RBC membrane Na+-K+ ATPase activity, serum magnesium and tyrosine/tryptophan catabolic patterns were assessed. The free radical metabolism, glycoconjugate metabolism and RBC membrane composition were also assessed.
RESULTS: Membrane Na+-K+ ATPase activity and serum magnesium levels were decreased while HMG-CoA reductase activity and serum digoxin levels were increased in CFS. There were increased levels of tryptophan catabolites - nicotine, strychnine, quinolinic acid and serotonin - and decreased levels of tyrosine catabolites -dopamine, norepinephrine and morphine - in CFS. There was an increase in dolichol levels, carbohydrate residues of glycoproteins, glycolipids, total/individual glycosaminoglycans (GAG) fractions and lysosomal enzymes in CFS. Reduced levels of ubiquinone, reduced glutathione and free radical scavenging enzymes as well as increased lipid peroxidation products and nitric oxide were noticed in CFS. The biochemical patterns in CFS correlated with those obtained in right hemispheric dominance.
CONCLUSIONS: The role of hypothalamic digoxin and neurotransmitter-induced immune activation, altered glycoconjugate metabolism and resultant defective viral antigen presentation, NMDA excitotoxicity and cognitive and mitochondrial dysfunction in the pathogenesis of CFS is stressed. CFS occurs in individuals with right hemispheric dominance.

Entities:  

Year:  2003        PMID: 26983655     DOI: 10.1034/j.1601-5215.2003.00045.x

Source DB:  PubMed          Journal:  Acta Neuropsychiatr        ISSN: 0924-2708            Impact factor:   3.403


  5 in total

Review 1.  The Link Between Energy-Related Sensations and Metabolism: Implications for Treating Fatigue.

Authors:  Marco Filippi; Rainer Krähenmann; Patrick Fissler
Journal:  Front Psychol       Date:  2022-06-21

2.  Metabolomics study of fatigue in patients with rheumatoid arthritis naïve to biological treatment.

Authors:  Izabella Surowiec; Clara Gram Gjesdal; Grete Jonsson; Katrine Brække Norheim; Torbjörn Lundstedt; Johan Trygg; Roald Omdal
Journal:  Rheumatol Int       Date:  2016-01-23       Impact factor: 2.631

Review 3.  Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.

Authors:  Gerwyn Morris; George Anderson; Michael Berk; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-06-13       Impact factor: 5.590

Review 4.  Vitamin and mineral status in chronic fatigue syndrome and fibromyalgia syndrome: A systematic review and meta-analysis.

Authors:  Monica L Joustra; Isidor Minovic; Karin A M Janssens; Stephan J L Bakker; Judith G M Rosmalen
Journal:  PLoS One       Date:  2017-04-28       Impact factor: 3.240

Review 5.  Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 'long-haulers'?

Authors:  Emily Wood; Katherine H Hall; Warren Tate
Journal:  Chronic Dis Transl Med       Date:  2020-11-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.